Matrixx Initiatives, Inc. (NASDAQ:MTXX) skyrocketed 56.09% to $7.99.
The company announced that it has entered into a definitive merger agreement to
be acquired by investment funds managed by H.I.G. Capital, LLC, a global
private investment firm.
Under the terms of the merger agreement, affiliates of H.I.G. will
commence a tender offer to purchase for cash all of the outstanding shares of
Matrixx common stock, and the associated preferred stock purchase rights, at a
price of $8.00 per share, which represents a 56.3% premium to the Company's closing
stock price on December 13, 2010, the last full trading day before today's
announcement, for a total value of approximately $75.2 million.
Genoptix, Inc. (NASDAQ:GXDX) soared 15.46% to $20.76 after
Bloomberg reported the cancer-testing firm was seeking a buyer.
The stock opened at $21.27 and is trading within the range of
$20.25-$21.44. At current market price, the market capitalization of the
company stands at $365.39 million.
Exelixis, Inc. (NASDAQ:EXEL) jumped
7.05% to $7.29. Exelixis, Inc. is focused on discovering, developing and
commercializing therapies for the treatment of cancer and other serious
diseases. The majority of its programs focus on discovery and development of
small molecule drugs for cancer.
Over the past five trading sessions, the stock jumped over 23%.
Article published by Wall Street Grand. Visit the Wall Street Grand Club today. For our full disclosure please visit - http://www.wallstreetgrand.com/disclosure.html
